Gabay, C., Burmester, G. R., Strand, V., Msihid, J., Zilberstein, M., Kimura, T., . . . Boyapati, A. (2020). Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes. Arthritis Res Ther.
Citação norma ChicagoGabay, Cem, et al. "Sarilumab and Adalimumab Differential Effects On Bone Remodelling and Cardiovascular Risk Biomarkers, and Predictions of Treatment Outcomes." Arthritis Res Ther 2020.
Citação norma MLAGabay, Cem, et al. "Sarilumab and Adalimumab Differential Effects On Bone Remodelling and Cardiovascular Risk Biomarkers, and Predictions of Treatment Outcomes." Arthritis Res Ther 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.